| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 04/29/2004 | CA2501547A1 Substituted indoles and their use as hcv inhibitors |
| 04/29/2004 | CA2501539A1 Benzimidazole derivatives and their use as vanilloid receptor ligands |
| 04/29/2004 | CA2501418A1 Novel compounds |
| 04/29/2004 | CA2500320A1 Novel compounds with antibacterial activity |
| 04/29/2004 | CA2500083A1 Tetrahydroquinoline derivatives as crth2 antagonists |
| 04/28/2004 | EP1413580A1 Furanone derivatives as inhibitors of Cathepsin S |
| 04/28/2004 | EP1413576A2 Substituted imidazole derivatives having agonist-like activity at alpha 2B or 2B/2C adrenergic receptors |
| 04/28/2004 | EP1413306A1 Tetrahydroquinoline derivatives as CRTH2 antagonists |
| 04/28/2004 | EP1412376A2 Compositions and methods for labeling oligonucleotides |
| 04/28/2004 | EP1412364A1 Platelet adp receptor inhibitors |
| 04/28/2004 | EP1412351A1 Reductive cleavage of the exocyclic ester of uk-2a or its derivatives and products formed therefrom |
| 04/28/2004 | EP1412350A1 Paroxetine isethionate salt, process of preparation and use in the treatment of depression |
| 04/28/2004 | EP1412349A2 Piperazine oxyquinoline (naphthaline) platelet adenosine diphosphate receptor antagonists |
| 04/28/2004 | EP1412348A1 Compounds derived from diaminopyrazole substituted by a heteroaromatic radical and their use in oxidation dyeing of keratinous fibres |
| 04/28/2004 | EP1412344A1 Iodobenzopyran-4-one derivatives having fungicidal activity |
| 04/28/2004 | EP1412343A1 New compounds, which are potent inhibitors of na+/ca2+ exchange mechanism and are useful in the treatment of arrhythmias |
| 04/28/2004 | EP1412327A2 Inhibitors of protein kinase for the treatment of disease |
| 04/28/2004 | EP1411954A2 Modified nucleosides for treatment of viral infections and abnormal cellular proliferation |
| 04/28/2004 | EP1411948A1 Tetrahydroquinoxalines acting as bradykinin antagonists |
| 04/28/2004 | EP1411945A1 Substituted pyridin-4-ones and their use as gonadotropin-releasing hormone receptor antagonists |
| 04/28/2004 | EP1411944A1 Sulfonamide derivatives as gamma secretase inhibitors |
| 04/28/2004 | EP1411942A1 Substituted anilinic piperidines as mch selective antagonists |
| 04/28/2004 | EP1411928A1 Viral polymerase inhibitors |
| 04/28/2004 | EP1042313B1 Benzopyran and benzothiopyran derivatives having retinoid antagonist like activity |
| 04/28/2004 | EP0513200B2 Method and compositions for the synthesis of bch-189 and related compounds |
| 04/28/2004 | CN1492865A š�-lactam compounds, process for producing the same and serum cholesterol-lowering agents containing the same |
| 04/28/2004 | CN1492860A 喹唑啉衍生物 Quinazoline derivatives |
| 04/28/2004 | CN1492856A Pyridone derivative having affinity for cannabinoid 2-type receptor |
| 04/28/2004 | CN1491949A Pyridazine-3-one derivatives, their use, and intermediate preparing them |
| 04/28/2004 | CN1491947A C10 ester carbonate substituted taxadane |
| 04/28/2004 | CN1491946A C 10 ester substituted taxadane |
| 04/28/2004 | CN1491941A Heterobicyclic sulfonamide derivative and sulfonic ester derivative |
| 04/28/2004 | CN1147504C New thrombin inhibitors, their preparation and use |
| 04/28/2004 | CN1147486C 4-and 5-alkynyloxindoles and 4-and 5-alkenyloxindoles |
| 04/28/2004 | CN1147476C Pyrazole derivatives as P-38 MAP kinase inhibitors |
| 04/27/2004 | US6727364 Antiinflammatory agents |
| 04/27/2004 | US6727275 Pyrrolidinone derivatives |
| 04/27/2004 | US6727264 Substituted anilinic piperidines as MCH selective antagonists |
| 04/27/2004 | US6727263 Serotonine reuptake inhibitor; antidepressants; side effect reduction |
| 04/27/2004 | US6727257 Hypotensive agents for intraocular pressure; anticholesterol agents; relaxing urinary tract tissue; benign prostatic hyperplasia, impotency, and cardiovascular disorders; antiarrhythmia agents |
| 04/27/2004 | US6727256 4-aminoquinazoline derivatives as anticarcinogenic agents |
| 04/27/2004 | US6727251 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease |
| 04/27/2004 | US6727250 Administering compounds such as trans-3-(naphth-2-yl)-but-2-enoic acid-n-(2-carboxy-phenyl)-amide or like for therapy of conditions associated with increased telomerase activity, e.g. tumour diseases |
| 04/27/2004 | US6727248 Substituted quinolinecarboxamides as antiviral agents |
| 04/27/2004 | US6727244 Mammalian metabolites of a tachykinin receptor antagonist |
| 04/27/2004 | US6727239 Inhibitory activity on no- synthase enzymes producing nitrogen monoxide no and/or an activity which traps the reactive oxygen species (ros) |
| 04/27/2004 | CA2299400C Method for treating disease-related or drug-induced dyskinesias |
| 04/27/2004 | CA2136745C Heterocyclically disubstituted sulphonylamino(thio)carbonyl compounds |
| 04/22/2004 | WO2004033632A2 Hydantoin derivatives as inhibitors of matrix metalloproteinases and/or tnf-alpha converting enzyme (tace) |
| 04/22/2004 | WO2004033447A1 Imidazole derivatives and their use as peripherally-selective inhibitors of dopamine-beta-hydroxylase |
| 04/22/2004 | WO2004033435A1 Quinazolinone derivatives useful as anti-hyperalgesic agents |
| 04/22/2004 | WO2004033434A1 Pyrazole compounds for treatment of neurodegenerative disorders |
| 04/22/2004 | WO2004033428A1 Substituted 1,4-di-piperidin-4-yl-piperazine derivatives and their use as neurokinin antagonists |
| 04/22/2004 | WO2004033427A1 1,4-disubstituted piperidine derivatives and their use as 11-betahsd1 inhibitors |
| 04/22/2004 | WO2004033422A2 Modulation of anxiety through blockade of anandamide hydrolysis |
| 04/22/2004 | WO2004032908A2 Method of inhibiting angiogenesis |
| 04/22/2004 | WO2004032871A2 Piperazine and piperazinone inhibitors of factor xa |
| 04/22/2004 | WO2004032848A2 Pgd2 receptor antagonists for the treatment of inflammatory diseases |
| 04/22/2004 | WO2004032846A2 Triazolone and triazolethione derivatives |
| 04/22/2004 | WO2004032845A2 R-nsaid esters and their use |
| 04/22/2004 | WO2004022544A8 Novel aminoindazole derivatives as medicines and pharmaceutical compositions containing same |
| 04/22/2004 | WO2004020430A3 Derivatives of dioxane-2-alkyl carbamates, preparation method thereof and application of same in therapeutics |
| 04/22/2004 | WO2004020410A3 Dihydropyridinone derivatives as hne inhibitors |
| 04/22/2004 | WO2004016597A3 Protein kinase inhibitors and uses thereof |
| 04/22/2004 | WO2004014300A3 Tyrosine kinase inhibitors |
| 04/22/2004 | WO2004002986A3 Novel benzimidazole derivatives |
| 04/22/2004 | WO2003082263A8 Sulfamic acids as inhibitors of human cytoplasmic protein tyrosine phosphatases |
| 04/22/2004 | WO2003078403A3 Derives d’aminoindazoles comme inhibiteurs de proteine-kinase |
| 04/22/2004 | WO2003072541A3 Chemical compounds |
| 04/22/2004 | WO2003005999A8 Methods of treating cytokine mediated diseases |
| 04/22/2004 | WO2002074767A8 Metalloproteinase inhibitors |
| 04/22/2004 | WO2002074752A8 Metalloproteinase inhibitors |
| 04/22/2004 | WO2002074748A8 Metalloproteinase inhibitors |
| 04/22/2004 | US20040077877 Jun n-terminal kinase inhibitors |
| 04/22/2004 | US20040077861 Asymmetric addition of organometallic compounds to chiral sulfinimine to give adducts in predominantly one diastereomer can subsequently be transferred into pure enantiomers of by cleavage of the chiral auxilliary |
| 04/22/2004 | US20040077712 Resolution with acid; salt formation, cyclization |
| 04/22/2004 | US20040077707 Pyrrole based inhibitors of glycogen synthase kinase 3 |
| 04/22/2004 | US20040077706 Piperidine and azepine derivatives; anxiolytic, analgesic, antidepressant, antiemetic, antiinflammatory, and hypotensive agents; sexual and psychological disorders; Alzheimer*s, Parkinson*s, Lesche-Nyhane, Wilson*s, and Tourette*s syndrome |
| 04/22/2004 | US20040077702 Administering indazole derivative; or thienyl-, furyl-, or pyrrolyl- fused pyrazole derivative to treat Alzheimer*s, Parkinson*s, or Huntington*s disease |
| 04/22/2004 | US20040077699 Substituted triazole diamine derivatives as kinase inhibitors |
| 04/22/2004 | US20040077693 Integrin receptor inhibitors |
| 04/22/2004 | US20040077684 Piperidinyl compounds that selectively bind integrins |
| 04/22/2004 | US20040077671 Sorbitol dehydrogenase inhibitors |
| 04/22/2004 | US20040077670 Novel sulfamides and their use as endothelin receptor antagonists |
| 04/22/2004 | US20040077668 Compounds, compositins, and methods |
| 04/22/2004 | US20040077667 Quinazolinone derivatives |
| 04/22/2004 | US20040077656 Quinolines and nitrogenated derivatives thereof substituted in 4-position by a piperazine-containing moiety and their use as antibacterial agents |
| 04/22/2004 | US20040077655 Piperazine derivatives for treatment of bacterial infections |
| 04/22/2004 | US20040077654 Anticholesterol agents; cardiovascular disorders |
| 04/22/2004 | US20040077650 Cannabinoid receptor ligands and uses thereof |
| 04/22/2004 | US20040077648 Antiproliferative agents for smooth muscle cells; antiinflammatory agents for endothelial cells; restenosis, atherosclerosis |
| 04/22/2004 | US20040077647 Fluorinated di-aryl urea compounds |
| 04/22/2004 | US20040077646 Indole nitriles |
| 04/22/2004 | US20040077644 Administering quinoline derivative as analgesic |
| 04/22/2004 | US20040077643 3,4 Dihydroisoquinoline derivative compounds and drugs containing these compounds as the active ingredient |
| 04/22/2004 | US20040077641 Insecticides for crops |
| 04/22/2004 | US20040077635 Trypsin-like serine protease inhibitors; treating thromboembolic disorders; anticoagulants |
| 04/22/2004 | CA2501611A1 1,4-disubstituted piperidine derivatives and their use as 11-betahsd1 inhibitors |
| 04/22/2004 | CA2501529A1 Quinazolinone derivatives useful as anti-hyperalgesic agents |
| 04/22/2004 | CA2501506A1 Modulation of anxiety through blockade of anandamide hydrolysis |